Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Examination of cocaine dose in a preclinical model of natural reward devaluation by cocaine.

Green JL, Dykstra LA, Carelli RM.

Behav Pharmacol. 2015 Jun;26(4):398-402. doi: 10.1097/FBP.0000000000000131.

2.

Obituary: J. David LEander, Ph.D. : (April 8, 1944-November 14, 2014).

Witkin JM, Gleason SD, Carter RB, Dykstra LA.

Psychopharmacology (Berl). 2015 Apr;232(7):1175-6. doi: 10.1007/s00213-015-3885-2. Epub 2015 Feb 21. No abstract available.

PMID:
25697862
3.

Thermal sensitivity as a measure of spontaneous morphine withdrawal in mice.

Balter RE, Dykstra LA.

J Pharmacol Toxicol Methods. 2013 May-Jun;67(3):162-8. doi: 10.1016/j.vascn.2013.02.003. Epub 2013 Feb 14.

4.

The effect of environmental factors on morphine withdrawal in C57BL/6J mice: running wheel access and group housing.

Balter RE, Dykstra LA.

Psychopharmacology (Berl). 2012 Nov;224(1):91-100. doi: 10.1007/s00213-012-2826-6. Epub 2012 Aug 19.

PMID:
22903388
5.

Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice.

Miller LL, Picker MJ, Umberger MD, Schmidt KT, Dykstra LA.

J Pharmacol Exp Ther. 2012 Jul;342(1):177-87. doi: 10.1124/jpet.112.191478. Epub 2012 Apr 18.

6.

Metabotropic glutamate antagonists alone and in combination with morphine: comparison across two models of acute pain and a model of persistent, inflammatory pain.

Picker MJ, Daugherty D, Henry FE, Miller LL, Dykstra LA.

Behav Pharmacol. 2011 Dec;22(8):785-93. doi: 10.1097/FBP.0b013e32834d13a2.

7.

Opioid antinociception, tolerance and dependence: interactions with the N-methyl-D-aspartate system in mice.

Dykstra LA, Fischer BD, Balter RE, Henry FE, Schmidt KT, Miller LL.

Behav Pharmacol. 2011 Sep;22(5-6):540-7. doi: 10.1097/FBP.0b013e328348ed08.

8.

Effects of morphine on pain-elicited and pain-suppressed behavior in CB1 knockout and wildtype mice.

Miller LL, Picker MJ, Schmidt KT, Dykstra LA.

Psychopharmacology (Berl). 2011 Jun;215(3):455-65. doi: 10.1007/s00213-011-2232-5. Epub 2011 Mar 4.

9.

Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.

Fischer BD, Ward SJ, Henry FE, Dykstra LA.

Neuropharmacology. 2010 Feb;58(2):544-50. doi: 10.1016/j.neuropharm.2009.08.005. Epub 2009 Aug 21.

10.

The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse.

Ward SJ, Rosenberg M, Dykstra LA, Walker EA.

Drug Alcohol Depend. 2009 Dec 1;105(3):248-55. doi: 10.1016/j.drugalcdep.2009.07.002. Epub 2009 Aug 12.

11.

Chronic unpredictable stress enhances cocaine-conditioned place preference in type 1 cannabinoid receptor knockout mice.

Miller LL, Ward SJ, Dykstra LA.

Behav Pharmacol. 2008 Sep;19(5-6):575-81. doi: 10.1097/FBP.0b013e32830ded11.

12.

Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).

Fischer BD, Miller LL, Henry FE, Picker MJ, Dykstra LA.

Psychopharmacology (Berl). 2008 Jun;198(2):271-8. doi: 10.1007/s00213-008-1130-y. Epub 2008 Apr 8.

PMID:
18392754
13.

Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine.

Ramsey AJ, Laakso A, Cyr M, Sotnikova TD, Salahpour A, Medvedev IO, Dykstra LA, Gainetdinov RR, Caron MG.

Neuropsychopharmacology. 2008 Oct;33(11):2701-14. doi: 10.1038/sj.npp.1301663. Epub 2008 Jan 9.

14.

Morphine in combination with metabotropic glutamate receptor antagonists on schedule-controlled responding and thermal nociception.

Fischer BD, Zimmerman EI, Picker MJ, Dykstra LA.

J Pharmacol Exp Ther. 2008 Feb;324(2):732-9. Epub 2007 Nov 2.

PMID:
17982001
15.
16.
17.

Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice.

Carrigan KA, Dykstra LA.

Psychopharmacology (Berl). 2007 May;191(4):985-93. Epub 2007 Jan 9.

PMID:
17211651
18.
20.

Morphine tolerance as a function of ratio schedule: response requirement or unit price?

Hughes CE, Sigmon SC, Pitts RC, Dykstra LA.

J Exp Anal Behav. 2005 May;83(3):281-96.

22.
23.

Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice.

Medvedev IO, Gainetdinov RR, Sotnikova TD, Bohn LM, Caron MG, Dykstra LA.

Psychopharmacology (Berl). 2005 Jul;180(3):408-13. Epub 2005 Feb 18.

PMID:
15719221
24.

Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist.

Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS.

Eur J Pharmacol. 2004 Oct 6;501(1-3):111-9.

PMID:
15464069
25.

Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.

Sotnikova TD, Budygin EA, Jones SR, Dykstra LA, Caron MG, Gainetdinov RR.

J Neurochem. 2004 Oct;91(2):362-73.

26.

Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery.

Bohn LM, Dykstra LA, Lefkowitz RJ, Caron MG, Barak LS.

Mol Pharmacol. 2004 Jul;66(1):106-12.

PMID:
15213301
27.

Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline.

Walker EA, Picker MJ, Granger A, Dykstra LA.

J Pharmacol Exp Ther. 2004 Jul;310(1):150-8. Epub 2004 Mar 25.

PMID:
15044559
28.

Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice.

Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, Dykstra LA, Caron MG.

J Neurosci. 2003 Nov 12;23(32):10265-73.

30.

Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure.

Dykstra LA, Granger AL, Allen RM, Zhang X, Rice KC.

Psychopharmacology (Berl). 2002 Oct;163(3-4):420-9. Epub 2002 May 25.

PMID:
12373443
31.

Marian W. Fischman: 1939-2001.

Johanson CE, Dykstra LA, Miczek KA.

Psychopharmacology (Berl). 2002 Apr;160(4):337-8. Epub 2002 Feb 21. No abstract available.

PMID:
11919659
32.

Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys.

Allen RM, Granger AL, Dykstra LA.

J Pharmacol Exp Ther. 2002 Feb;300(2):435-41.

PMID:
11805202
33.

Three-choice discrimination in pigeons is based on relative efficacy differences among opioids.

Walker EA, Picker MJ, Dykstra LA.

Psychopharmacology (Berl). 2001 Jun;155(4):389-96.

PMID:
11441428
34.
36.

Differential tolerance to morphine's immunomodulatory effects following continuous administration.

West JP, Dykstra LA, Lysle DT.

Drug Alcohol Depend. 1998 Dec 1;53(1):31-8.

PMID:
10933338
37.
38.

Immunomodulatory effects of morphine withdrawal in the rat are time dependent and reversible by clonidine.

West JP, Dykstra LA, Lysle DT.

Psychopharmacology (Berl). 1999 Oct;146(3):320-7.

PMID:
10541733
39.

Discriminative stimulus effects of nalbuphine in nontreated and morphine-treated pigeons.

Walker EA, Hawkins ER, Tiano MJ, Picker MJ, Dykstra LA.

Pharmacol Biochem Behav. 1999 Oct;64(2):445-8.

PMID:
10515328
40.

Naltrexone and beta-funaltrexamine antagonism of the antinociceptive and response rate-decreasing effects of morphine, dezocine, and d-propoxyphene.

Walker EA, Tiano MJ, Benyas SI, Dykstra LA, Picker MJ.

Psychopharmacology (Berl). 1999 May;144(1):45-53.

PMID:
10379623
41.

The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats.

Allen RM, Dykstra LA.

Psychopharmacology (Berl). 1999 Feb;142(2):209-14.

PMID:
10102774
42.

Morphine's immunologic and analgesic effects. Comparison of time course.

Nelson CJ, Dykstra LA, Lysle DT.

Adv Exp Med Biol. 1998;437:169-75. No abstract available.

PMID:
9666268
43.

Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.

Pitts RC, Allen RM, Walker EA, Dykstra LA.

J Pharmacol Exp Ther. 1998 Jun;285(3):1197-206.

PMID:
9618423
44.
45.

Comparison of the time course of morphine's analgesic and immunologic effects.

Nelson CJ, Dykstra LA, Lysle DT.

Anesth Analg. 1997 Sep;85(3):620-6.

PMID:
9296419
46.

Tolerance development to morphine-induced alterations of immune status.

West JP, Lysle DT, Dykstra LA.

Drug Alcohol Depend. 1997 Jul 4;46(3):147-57.

PMID:
9250473
47.

Antagonism of the response rate-decreasing effects of meperidine and morphine by beta-funaltrexamine and naltrexone in squirrel monkeys.

Hughes CE, Dykstra LA.

Drug Alcohol Depend. 1997 May 2;45(3):197-206. Erratum in: Drug Alcohol Depend 1997 Jul 25;47(1):75.

PMID:
9179521
48.

Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects.

Dykstra LA, Preston KL, Bigelow GE.

Psychopharmacology (Berl). 1997 Mar;130(1):14-27. Review.

PMID:
9089845
49.
50.

Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status.

Lysle DT, Hoffman KE, Dykstra LA.

J Pharmacol Exp Ther. 1996 Jun;277(3):1533-40. Erratum in: J Pharmacol Exp Ther 1996 Dec;279(3):1589.

PMID:
8667220

Supplemental Content

Loading ...
Support Center